Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Exelixis
The Netherlands Cancer Institute
M.D. Anderson Cancer Center
Neonc Technologies, Inc.
Bristol-Myers Squibb